Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions

PET/CTSolid Tumors, AdultSolid Tumors, Advanced Solid Tumors

Interventions

DIAGNOSTIC_TEST

PET/CT Imaging with GZMB-targeted tracer

Intravenous administration of GZMB-targeted tracer (150-200 MBq), followed by whole-body PET/CT scan 30\~60 minutes post-injection.

Trial Locations (1)

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors

lead

Zhongnan Hospital

OTHER

NCT06916442 - Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy | Biotech Hunter | Biotech Hunter